Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.1K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

7.2K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
7.2K
Vascular Spasm01:16

Vascular Spasm

2.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Replenishing interfacial lubrication: A cartilage-inspired polyzwitterionic dressing for spatiotemporal healing of friction-prone diabetic wound.

Biomaterials·2026
Same author

Interface Wettability Transition-Driven Drug Release and Dual-Phase Functionalization in Implant Abutment.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

A Natural Pueraria─Based Conductive Cardiac Patch with Tree Frog Foot─Inspired Morphology for Myocardial Infarction Treatment.

ACS nano·2026
Same author

Intelligent Responsive PLGA-ES100 Composite Nanoparticles Loaded with Resolvin E1 for Inflammation Regulation Behavior.

ACS applied bio materials·2025
Same author

Sulfide-based, pro-regenerative, anti-inflammatory vascular grafts: Impregnation of slow-released sulfide signals into graft implants.

Acta biomaterialia·2025
Same author

Programmed modulation of inflammation in diabetic wounds via a dual-stage CuTA/RvD1 microneedle system.

Biomaterials advances·2025

Related Experiment Video

Updated: Dec 3, 2025

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
08:42

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics

Published on: September 19, 2016

9.1K

Intelligent H2S release coating for regulating vascular remodeling.

Bingyang Lu1,2, Xiao Han1,2, Ansha Zhao1,2

  • 1Key Laboratory of Advanced Technologies of Materials, Ministry of Education, Southwest Jiaotong University, Chengdu, 610031, China.

Bioactive Materials
|October 26, 2020
PubMed
Summary

New pH-responsive films release hydrogen sulfide (H2S) to treat cardiovascular disease. This smart drug delivery system enhances blood vessel self-healing and offers precise treatment for atherosclerotic lesions.

Keywords:
Coronary atherosclerosisH2SLayer-by-layer self-assembly filmpH responsive

More Related Videos

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:17

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

667
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

654

Related Experiment Videos

Last Updated: Dec 3, 2025

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
08:42

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics

Published on: September 19, 2016

9.1K
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:17

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

667
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

654

Area of Science:

  • Biomaterials Science
  • Cardiovascular Research
  • Drug Delivery Systems

Background:

  • Coronary atherosclerotic lesions present a low-pH inflammatory environment.
  • Current drug-eluting stents lack precise drug release control, leading to complications like delayed endothelialization and thrombosis.

Purpose of the Study:

  • To develop pH-responsive self-assembling films for controlled drug delivery.
  • To utilize a hydrogen sulfide (H2S)-releasing aspirin derivative (ACS14) for enhanced vascular function and self-healing.

Main Methods:

  • Hyaluronic acid and chitosan were used to create pH-responsive self-assembling films.
  • The films incorporated an H2S-releasing aspirin derivative (ACS14).
  • Evaluated drug release profiles at varying pH, blood compatibility, cellular effects, and implantation outcomes.

Main Results:

  • The films demonstrated pH-responsive drug release, adjusting to the lesion's microenvironment.
  • The released H2S promoted vascular function and self-healing, comparable to nitric oxide (NO).
  • Experiments confirmed favorable blood compatibility, cellular interactions, and implantation performance.

Conclusions:

  • This novel self-assembled film technology offers a new therapeutic concept for cardiovascular diseases.
  • The condition-adjusted H2S release provides a precise treatment strategy for atherosclerotic lesions.
  • The approach enhances blood vessel self-healing and balances vascular function.